Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance

OBJECTIVE: The goal of this study was to monitor imatinib mesylate therapeutically in the Tumor Biology Laboratory, Department of Hematology and Hemotherapy, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (USP). A simple and sensitive method to quantify imatinib and its meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezende, Vinícius Marcondes, Rivellis, Ariane Julio, Gomes, Melissa Medrano, Dörr, Felipe Augusto, Novaes, Mafalda Megumi Yoshinaga, Nardinelli, Luciana, Costa, Ariel Lais de Lima, Chamone, Dalton de Alencar Fisher, Bendit, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672119/
https://www.ncbi.nlm.nih.gov/pubmed/23741187
http://dx.doi.org/10.5581/1516-8484.20130030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672119/
https://www.ncbi.nlm.nih.gov/pubmed/23741187
http://dx.doi.org/10.5581/1516-8484.20130030

Ejemplares similares